quinazolines has been researched along with pyrazole in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Gawad, SM; El-Gaby, MS; Ghorab, MM | 1 |
| Catarzi, D; Colotta, V; Costagli, C; Filacchioni, G; Galli, A; Lenzi, O; Varano, F | 1 |
| McLaughlin, ML; Talele, TT | 1 |
| Beijnen, JH; Pluim, D; Schellens, JH; van Tellingen, O | 1 |
| Gangarajula, S; Ghosh, AK; Huang, X; Kulkarni, S; Pandey, S; Rao, KV; Tang, J; Xu, X | 1 |
| Li, QS; Sun, S; Tang, JF; Wang, XL; Yang, YS; Zhang, F; Zhang, YB; Zhu, HL | 1 |
| Hu, C; Hu, J; Jin, Z; Ke, J; Lu, Q; Sun, R; Wan, DC; Wang, X; Zhan, X | 1 |
7 other study(ies) available for quinazolines and pyrazole
| Article | Year |
|---|---|
Synthesis and antifungal activity of novel pyrano[2',3':4,5]thiazolo[2,3-b]quinazolines, pyrido[2',3':4,5]thiazolo[2,3-b]quinazolines and pyrazolo[2',3':4,5]thiazolo[2,3-b]quinazolines.
Topics: Antifungal Agents; Aspergillus flavus; Aspergillus ochraceus; Candida albicans; Microbial Sensitivity Tests; Molecular Structure; Penicillium chrysogenum; Pyrans; Pyrazoles; Pyridines; Quinazolines; Thiazoles | 2000 |
Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: Synthesis and structure-activity relationships.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Molecular Structure; N-Methylaspartate; Pyrazoles; Quinazolines; Receptors, Kainic Acid; Structure-Activity Relationship | 2008 |
Molecular docking/dynamics studies of Aurora A kinase inhibitors.
Topics: Aurora Kinases; Binding Sites; Computer Simulation; Hydrogen Bonding; Indoles; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Quinazolines; Structure-Activity Relationship; Sulfonamides | 2008 |
Simultaneous determination of AZD1152 (prodrug) and AZD1152-hydroxyquinazoline pyrazol anilide by reversed phase liquid chromatography.
Topics: Animals; Chromatography, High Pressure Liquid; Humans; Hydroxyquinolines; Mice; Molecular Structure; Organophosphates; Pyrazoles; Quinazolines; Reproducibility of Results | 2009 |
Structure-based design, synthesis, and biological evaluation of dihydroquinazoline-derived potent β-secretase inhibitors.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Catalytic Domain; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Humans; Models, Molecular; Pyrazoles; Quinazolines; Structure-Activity Relationship; Thiazoles | 2012 |
Design, modification and 3D QSAR studies of novel 2,3-dihydrobenzo[b][1,4]dioxin-containing 4,5-dihydro-1H-pyrazole derivatives as inhibitors of B-Raf kinase.
Topics: Binding Sites; Cell Line, Tumor; Cell Proliferation; Dioxanes; Dioxins; Drug Design; Erlotinib Hydrochloride; Humans; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins B-raf; Pyrazoles; Quantitative Structure-Activity Relationship; Quinazolines; Thermodynamics | 2012 |
Discovery of 4,5-Dihydro-1
Topics: A549 Cells; ErbB Receptors; Gefitinib; Hep G2 Cells; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Protein Kinase Inhibitors; Pyrazoles; Quinazolines | 2018 |